ABUS vs WH · P/E 5.4, rev $6.2M vs P/E 20, rev $1.43B
Arbutus Biopharma Corp (ABUS) versus Wyndham Hotels & Resorts Inc (WH) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Wyndham Hotels & Resorts Inc (WH) is a lodging company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported WH revenue for 2025-12-31 was $1.43B. Net income was $193.0M. Revenue was up 1.5% from 2024-12-31 to 2025-12-31. WH currently screens at market cap $6.51B and trailing P/E 20.1.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. WH currently screens at market cap $6.51B and trailing P/E 20.1.
Not investment advice. Open the ABUS and WH stock pages for the full models.
Not investment advice.